We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
+2.66%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$2.31B
AUM Growth
+$149M
Cap. Flow
+$103M
Cap. Flow %
4.46%
Top 10 Hldgs %
56.22%
Holding
81
New
1
Increased
46
Reduced
7
Closed
3

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$46.5M
2
CB icon
Chubb
CB
+$44.1M
3
KGC icon
Kinross Gold
KGC
+$31.2M
4
EBAY icon
eBay
EBAY
+$3.77M
5
CFMS
Conformis, Inc. Common Stock
CFMS
+$1.54M

Sector Composition

Rank Sector Weight
1 Financials 29.24%
2 Communication Services 20.67%
3 Healthcare 12.47%
4 Technology 10.89%
5 Energy 7.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AERI
51
DELISTED
Aerie Pharmaceuticals
AERI
$2.31M 0.1%
120,000
+10,000
+9% +$229K
L icon
52
Loews
L
$24.5B
$2.24M 0.1%
43,472
VIV icon
53
Telefônica Brasil
VIV
$20.4B
$2.21M 0.1%
167,587
AKCA
54
DELISTED
Akcea Therapeutics Inc
AKCA
$1.85M 0.08%
120,286
EHC icon
55
Encompass Health
EHC
$11.3B
$1.76M 0.08%
34,996
SHG icon
56
Shinhan Financial Group
SHG
$32.1B
$1.67M 0.07%
47,773
XENE icon
57
Xenon Pharmaceuticals
XENE
$6.1B
$1.62M 0.07%
180,000
ARA
58
DELISTED
American Renal Associates Holdings, Inc
ARA
$1.39M 0.06%
220,000
CSCO icon
59
Cisco
CSCO
$443B
$1.39M 0.06%
28,040
VIPS icon
60
Vipshop
VIPS
$7.26B
$1.37M 0.06%
153,615
+28,000
+22% +$229K
KURA icon
61
Kura Oncology
KURA
$793M
$1.36M 0.06%
90,000
-5,000
-5% -$89K
DRNA
62
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$1.29M 0.06%
90,000
AGTC
63
DELISTED
Applied Genetic Technologies Corporation
AGTC
$1.28M 0.06%
306,900
IBN icon
64
ICICI Bank
IBN
$107B
$1.26M 0.05%
103,615
-49,606
-32% -$582K
NTES icon
65
NetEase
NTES
$83B
$1.18M 0.05%
22,200
-3,020
-12% -$154K
PRQR icon
66
ProQR Therapeutics
PRQR
$244M
$1.16M 0.05%
201,360
FTSV
67
DELISTED
Forty Seven, Inc. Common Stock
FTSV
$1.09M 0.05%
170,000
+30,000
+21% +$246K
FATE icon
68
Fate Therapeutics
FATE
$275M
$1.09M 0.05%
70,000
AAC
69
DELISTED
AAC Holdings
AAC
$1.05M 0.05%
1,574,370
+118,652
+8% +$99K
ELGX
70
DELISTED
Endologix Inc
ELGX
$1.05M 0.05%
265,000
+25,000
+10% +$145K
JOYY
71
JOYY Inc
JOYY
$3.73B
$939K 0.04%
16,690
CNDT icon
72
Conduent
CNDT
$253M
$862K 0.04%
138,576
FITB
73
Fifth Third Bancorp
FITB
$51.3B
$795K 0.03%
29,041
JD icon
74
JD.com
JD
$43.5B
$710K 0.03%
25,190
+7,434
+42% +$225K
TCOM icon
75
Trip.com Group
TCOM
$29B
$445K 0.02%
+15,201
New +$534K

Similar funds

Altrinsic Global Advisors's Q3 2019 Portfolio in Review

As of Q3 2019, Altrinsic Global Advisors held 81 positions worth $2.31B, up 6.9% from $2.16B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Altrinsic Global Advisors deployed $103M of net new capital in Q3 2019, opening 1 new position and adding to 46 existing holdings. Its largest new stake was Trip.com Group: 15,201 shares worth $445K.

By sector, the portfolio is most concentrated in Financials at 29% of assets, down from 31% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $46.5M trimmed.

  • Altrinsic Global Advisors's largest Q3 2019 buy was Trip.com Group: 15,201 shares worth $445K.
  • Altrinsic Global Advisors added most to Check Point Software Technologies in Q3 2019, an estimated $36.8M increase.
  • Altrinsic Global Advisors's biggest Q3 2019 reduction was Medtronic, cutting an estimated $46.5M.
  • Altrinsic Global Advisors fully exited Conformis, Inc. Common Stock in Q3 2019, selling an estimated $1.54M.
  • Altrinsic Global Advisors's ten largest holdings make up 56% of its $2.31B portfolio in Q3 2019.
  • Altrinsic Global Advisors opened 1 new position and closed 3 in Q3 2019.
  • Altrinsic Global Advisors's portfolio value rose 6.9% quarter-over-quarter to $2.31B.

Based on Altrinsic Global Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.